EPCS

HCA Healthcare Collects 13,136 Pounds of Medication During Fifth Annual “Crush the Crisis”

Retrieved on: 
Wednesday, December 6, 2023

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it collected 13,136 pounds of unused or expired medications during its fifth annual “Crush the Crisis” prescription drug take back day on October 28, 2023.

Key Points: 
  • HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it collected 13,136 pounds of unused or expired medications during its fifth annual “Crush the Crisis” prescription drug take back day on October 28, 2023.
  • HCA Healthcare has now collected more than 67,500 pounds of medication since launching “Crush the Crisis” as an enterprise initiative in 2019.
  • An estimated 9 million doses of medication were collected at 132 collection sites across 15 states.
  • HCA Healthcare’s “Crush the Crisis” events were held in alignment with the Drug Enforcement Administration’s (DEA) National Prescription Drug Take Back Day, which collected 599,897 pounds of medication .

Global Identity and Access Management Market to Accrue a Valuation of $35.25 billion by 2030, Registering a Strong CAGR of 11.30%, Primarily Driven by Increasing Incidences of Cybercrimes, States Kings Research

Retrieved on: 
Friday, December 8, 2023

The healthcare sector is projected to experience a substantial increase in the need for strong identity and access management (IAM) systems to comply with regulatory standards such as HIPAA and EPCS.

Key Points: 
  • The healthcare sector is projected to experience a substantial increase in the need for strong identity and access management (IAM) systems to comply with regulatory standards such as HIPAA and EPCS.
  • IAM solutions will play a vital role in safeguarding sensitive information and enabling healthcare providers to adhere to industry regulations.
  • Additionally, the regional market growth is projected to be impelled by the rising demand for cybersecurity management and data protection.
  • For more information on the report, visit: https://www.kingsresearch.com/identity-and-access-management-market-240
    Chapter 6 Global Identity And Access Management Market, By Component
    Chapter 7 Global Identity And Access Management Market, By Deployment
    Chapter 8 Global Identity And Access Management Market, By Vertical
    Chapter 9 Global Identity And Access Management Market, By Geography

First-of-its-kind Imprivata facial recognition technology transforms clinician and patient experiences by enabling EPCS order signing from mobile devices

Retrieved on: 
Thursday, October 26, 2023

“Catholic Health physicians have embraced the power of Imprivata Mobile EPCS, unlocking a new realm of flexibility and convenience in signing orders from any location,” said Diana Massaria, Sr. Director of Ambulatory Digital and Technology solutions at Catholic Health Services of Long Island.

Key Points: 
  • “Catholic Health physicians have embraced the power of Imprivata Mobile EPCS, unlocking a new realm of flexibility and convenience in signing orders from any location,” said Diana Massaria, Sr. Director of Ambulatory Digital and Technology solutions at Catholic Health Services of Long Island.
  • “This transformative tool has not only elevated patient and provider satisfaction but has also seamlessly integrated into their workflow, thanks to its user-friendly interface and an easy enrollment process.”
    As healthcare embraces mobile technology , the ability to prescribe directly from mobile devices is critical to enabling seamless clinical workflows.
  • However, providers have historically used laptops or desktops to complete EPCS orders due to technology challenges and regulatory restrictions.
  • Imprivata’s new facial recognition technology overcomes these challenges by delivering a fast, easy authentication experience that complies with DEA requirements for EPCS.

Juno Health Successfully Completes SOC 2 Type 2 Audit for Juno EHR, Juno Emergency Services Solution (JESS) and Juno RxTracker Offerings

Retrieved on: 
Friday, September 29, 2023

JUNO BEACH, Fla., Sept. 29, 2023 /PRNewswire-PRWeb/ -- Juno Health, the commercial division of DSS, Inc., today announced its successful completion of its SOC 2 Type 2 audit for Juno EHR, its Acute Care and Behavioral Health EHR systems, Juno Emergency Solutions (JESS), its emergency department EHR, and Juno RxTracker, its EPCS certified, e-Prescribing solution.

Key Points: 
  • JUNO BEACH, Fla., Sept. 29, 2023 /PRNewswire-PRWeb/ -- Juno Health , the commercial division of DSS, Inc., today announced its successful completion of its SOC 2 Type 2 audit for Juno EHR, its Acute Care and Behavioral Health EHR systems , Juno Emergency Solutions ( JESS ), its emergency department EHR, and Juno RxTracker, its EPCS certified, e-Prescribing solution.
  • As with the recent SOC 2 Type 1 audit , assessor A-LIGN, a technology-enabled security and compliance partner trusted by more than 2,500 global organizations to help mitigate cybersecurity risks, conducted the SOC 2 Type 2 on behalf of Juno Health.
  • In addition, Juno EHR for Behavioral Health is designed to support behavioral health processes around patient safety and data sharing.
  • "Congratulations to Juno Health for completing their SOC 2 audit, a widely recognized signal of trust and security," said Steve Simmons, COO of A-LIGN.

Juno Health Successfully Completes SOC 2 Audit for Juno Emergency Services Solution (JESS) and Juno RxTracker Offerings

Retrieved on: 
Thursday, June 29, 2023

JUNO BEACH, Fla., June 29, 2023 /PRNewswire-PRWeb/ -- Juno Health, the commercial division of DSS, Inc., today announced its successful completion of its SOC 2 Type 1 audit for its Juno Emergency Services Solution (JESS) and Juno RxTracker offerings, as part of its commitment to security and developing smarter, more flexible digital healthcare solutions.

Key Points: 
  • JUNO BEACH, Fla., June 29, 2023 /PRNewswire-PRWeb/ -- Juno Health , the commercial division of DSS, Inc., today announced its successful completion of its SOC 2 Type 1 audit for its Juno Emergency Services Solution ( JESS ) and Juno RxTracker offerings, as part of its commitment to security and developing smarter, more flexible digital healthcare solutions.
  • "Maintaining the highest-level of patient confidentiality, security, and compliance is paramount in healthcare," said J. Michael Fehr, Vice President, Commercial Operations at Juno Health.
  • "A SOC 2 audit is a statement about an organization's commitment to protecting their information," said Stephanie Oyler-Rankin, SOC Practice Lead at A-LIGN.
  • Juno Health's SOC 2 report validates its commitment to data security and protection, as well as compliance with critical standards to mitigate cybersecurity threats."

BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America

Retrieved on: 
Thursday, June 8, 2023

Research suggests that aesthetic medicine is experiencing an explosion in consumer adoption and is proving to be increasingly recession resilient.

Key Points: 
  • Research suggests that aesthetic medicine is experiencing an explosion in consumer adoption and is proving to be increasingly recession resilient.
  • Cosmetic surgeons and physicians from a variety of disciplines are benefiting from the increased demand for facial and body enhancement procedures utilizing minimally invasive procedures.
  • "We are thrilled to incorporate DrFirst's medication management solutions into our industry-leading practice management platform," said Jerome Dwight, CEO and co-founder of BoomerangFX.
  • "We are pleased to partner with BoomerangFX," said G. Cameron Deemer, CEO of DrFirst.

Dayton Children's Hospital Bridges Epic Hyperdrive Migration with PortalGuard® IAM Cloud to Expand its Utilization of BIO-key Identity-Bound Biometrics

Retrieved on: 
Tuesday, April 11, 2023

PortalGuard’s standards-based integration with Hyperdrive allows Dayton Children’s to continue enjoying BIO-key’s streamlined biometric authentication user experience for Epic security without re-enrollment or adoption of more cumbersome, shareable, and expensive multi-factor authentication solutions.

Key Points: 
  • PortalGuard’s standards-based integration with Hyperdrive allows Dayton Children’s to continue enjoying BIO-key’s streamlined biometric authentication user experience for Epic security without re-enrollment or adoption of more cumbersome, shareable, and expensive multi-factor authentication solutions.
  • Hyperdrive is Epic’s new browser-based application platform intended to replace its client-server Citrix-based Hyperspace end-user interface.
  • Hyperdrive’s browser-based access improves security, makes deploying and updating applications easier and allows for more choice in third-party authentication providers.
  • "Many of BIO-key’s hospital customers use Epic, and most are already in Hyperdrive migration engagements with our technical team," said Mark Cochran, President of BIO-key – PortalGuard.

iCoreConnect Inc. Delivers Strong Financial Results in 2022 With 60% Revenue Growth

Retrieved on: 
Thursday, March 23, 2023

iCoreConnect continued to deliver strong financial results with 2022 revenues growing 60% to $8MM versus $5MM in 2021.

Key Points: 
  • iCoreConnect continued to deliver strong financial results with 2022 revenues growing 60% to $8MM versus $5MM in 2021.
  • This growth was primarily driven by organic growth with a 20% increase in the number of subscribers year-over-year and additional uptake on product offerings for existing subscribers.
  • We have growth across all products and have launched additional add-on services based on feedback from customers.
  • And, we continue to see growing adoption by enterprise level clients.”
    McDermott continued, “iCoreConnect is primed for growth.

iCoreConnect, Inc. Expands Into Nebraska With Nebraska Dental Association Endorsement of iCoreRx ePrescription Software

Retrieved on: 
Tuesday, March 7, 2023

OCOEE, FL, March 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – iCoreConnect, Inc., (OTCQB: ICCT), a cloud-based Software-as-a-Service (SaaS) enterprise and healthcare workflow platform, today announced  the Nebraska Dental Association’s (NDA) endorsement of iCoreConnect’s cloud-based ePrescription software, iCoreRx.

Key Points: 
  • OCOEE, FL, March 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – iCoreConnect, Inc., (OTCQB: ICCT), a cloud-based Software-as-a-Service (SaaS) enterprise and healthcare workflow platform, today announced  the Nebraska Dental Association’s (NDA) endorsement of iCoreConnect’s cloud-based ePrescription software, iCoreRx.
  • iCoreRx, in combination with its powerful add-on feature to electronically prescribe controlled substances (EPCS), boasts more than 40 endorsement agreements by state dental and medical associations.
  • Nebraska, and states across the country, are impacted by laws requiring ePrescribing for medications, including controlled substances.
  • iCoreConnect President and CEO Robert McDermott elaborates, “We knew early-on the impact these laws would have on the dental industry.

AZZLY® Partners with Zoom® to Provide Secure Telehealth Sessions Seamlessly From AZZLY Rize™ All-in-One Mental Health Platform

Retrieved on: 
Monday, February 13, 2023

ORLANDO, Fla., Feb. 13, 2023 /PRNewswire-PRWeb/ -- AZZLY, Inc., a leading behavioral and addiction treatment digital health solution, announced today that it has formed an Independent Software Vendor (ISV) Partnership with the leader in digital video conferencing solutions, Zoom.

Key Points: 
  • Telehealth providers can now launch Zoom virtual sessions through a single sign-on in AZZLY's solution AZZLY Rize™.
  • As an all-in-one platform, AZZLY helps transform treatment centers to run more efficiently.
  • Additionally, on March 16, 2023, another webinar will follow titled "How to Use One Platform: AZZLY Rize™ + Zoom For Your Telehealth Model".
  • Attend to hear perspectives from both AZZLY and Zoom experts on the partnership and best practices for using telehealth within AZZLY's all-in-one platform.